The U.S. Air Force has issued policy changes with respect to waivers concerning eczema, asthma and attention deficit hyperactivity disorder (ADHD). Select candidates having mild forms of eczema will be processed for a waiver. Candidates who do not meet the current standard for ADHD will be processed for a waiver if they have demonstrated at least 15 months of performance stability off medication immediately preceding enlistment or enrollment and they continue to meet remaining criteria in Defense Department Instruction 6130.03. The Air Force will use the Methacholine Challenge Test to evaluate those candidates with an uncertain history of asthma. The waiver process changes are effective immediately.
For more Air Force news, visit the Military.com Air Force section. For more on joining the military, visit Military.com's Joining the Military section.
